Long-Acting Beta Agonists Revised Labeling Warns Of Asthma Death Potential
FDA issues revised labeling for GlaxoSmithKline’s Serevent, Advair, but continues to negotiate changes to Novartis/Schering’s Foradil.
FDA issues revised labeling for GlaxoSmithKline’s Serevent, Advair, but continues to negotiate changes to Novartis/Schering’s Foradil.